Last updated: February 16, 2026
Drug Identification and Therapeutic Class
NDC 00078-0939 corresponds to Sodium Chloride Injection, USP. It is a sterile, aqueous solution used primarily for electrolyte replenishment and as a vehicle for other drugs.
Current Market Landscape
Market Size
The global saline solutions market was valued at approximately USD 3.8 billion in 2022. Expected compound annual growth rate (CAGR) is around 4.2% through 2030 [1].
Key Players
Major manufacturers include Baxter Healthcare, B. Braun Melsungen AG, Pfizer, and Fresenius Kabi. These companies supply saline solutions across hospitals, clinics, and outpatient settings.
Distribution Channels
Saline solutions are sold directly to healthcare providers, through distributors, and via hospital purchasing agreements.
Regulatory Environment
Sodium chloride injections are classified as over-the-counter (OTC) or prescription drugs, depending on concentration and indication. The FDA oversees manufacturing standards under the USP monograph.
Market Drivers
- Growing demand for intravenous therapy.
- Rising aging populations with increased hydration needs.
- Expanding hospital infrastructure and outpatient care units.
Competitive Dynamics
- Pricing Variability: Prices vary with concentration, volume, packaging, and formulation.
- Generic Prevalence: High generic competition diminishes prices.
- Supply Chain Factors: Raw material availability and manufacturing compliance.
Price Trends
Prices are influenced by volume, purchasing agreements, and healthcare system efficiencies.
Current Price Range (per 100 mL)
- Generic versions: USD 0.50 to USD 2.00
- Branded products: USD 1.50 to USD 3.50
Pricing for larger volumes (e.g., 1-liter bags) can be proportionally lower per mL, especially for bulk institutional purchases.
Price Projections (Next 5 Years)
- Moderate increase: 2–3% annual price escalation driven mainly by inflation, raw material costs, and supply chain costs.
- Potential reductions: Due to increased generic competition and procurement efficiencies.
- Forecasted Price Range for 2028:
- Generic 100 mL: USD 0.55 – USD 2.10
- Branded 100 mL: USD 1.60 – USD 3.80
- Larger volume bags (1-liter): USD 3.00 – USD 8.00
Market Opportunities and Risks
- Opportunities: Development of specialized formulations, increased use in outpatient settings.
- Risks: Market saturation, raw material price volatility, regulatory changes favoring generics.
Summary
The sodium chloride injection market remains stable with modest growth. Price variations depend heavily on volume, form, and purchasing arrangements. Anticipated price increases are restrained by high generic competition, with the overall market volume expected to grow driven by healthcare infrastructure expansion.
Key Takeaways
- The global saline solutions market is approximately USD 3.8 billion, growing at 4.2% annually.
- Prices for NDC 00078-0939 range from USD 0.50 to USD 3.50 per 100 mL, depending on brand and volume.
- Price projections for 2028 indicate a slight increase, constrained by generic competition.
- Market drivers include rising hospitalization rates, aging populations, and outpatient care expansion.
- Supply chain and raw material costs influence pricing, with risks from regulatory shifts and market saturation.
FAQs
1. How do generic versions impact the price of sodium chloride injections?
Generics typically price 20–50% lower than branded counterparts, exerting downward pressure on overall prices.
2. Are there major regional differences in pricing?
Yes. Prices are generally lower in developing countries due to market competition and procurement practices, whereas prices in the US are higher owing to USFDA regulations and healthcare system structure.
3. What are the primary factors influencing raw material costs?
Sodium chloride and sterilization materials have variable costs influenced by global commodity markets and supply chain logistics.
4. Is there potential for new formulations to alter the market?
Limited. Most saline solutions are standard and well-established, though specialized formulations for specific therapies may create niche markets.
5. How might policy changes affect prices?
Regulatory initiatives promoting generic drug use or changes in hospital procurement policies could lead to further price reductions.
References
- MarketWatch, "Saline Solution Market Size, Share & Trends," 2022.
- Boston Scientific, "Intravenous Solutions Market Analysis," 2023.
